Stereotactic radiosurgery for the treatment of brain metastases: Impact of cerebral disease burden on survival

British Journal of Neurosurgery

Volumn 26, Issue 5, 2012, Pages 674-678

  Banfill, Kathryn E ^a   Bownes, Peter J ^a   St Clair, Shaun E ^a   Loughrey, Carmel ^a   Hatfield, Paul ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Brain metastasis; Gamma knife; Intracranial metastasis; Radiosurgery

Indexed keywords

STEROID;

ADULT; AGED; BRAIN METASTASIS; BREAST TUMOR; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; STEREOTACTIC RADIOSURGERY; STEROID THERAPY; SURGICAL TECHNIQUE; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84866112144     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688697.2012.690913     Document Type: Review

References (21)

1. Sawaya R, Bindal RK, Lang FF, Abi-Said D. Metastatic brain tumors. In: Kaye AH, Laws ER, Jr, eds. Brain tumors: An encyclopedic approach. 2nd ed. New York: Churchill Livingston; 2001: 999-1026.
2. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Th erapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-51. (Pubitemid 27181303)
3. Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classifi cation for brain metastases. Int J Radiat Oncol Biol Phys 2000;47:1001-6. (Pubitemid 30345599)
4. Weltman E, Salvajoli JV, Brandt RA, et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 2000;46:1155-61. (Pubitemid 30139425)
5. Ryken TC, McDermott M, Robinson PD, et al. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96:103-14.
6. Khanduri S, Gerrard G, Barton R, Mulvenna P, Lee SM. Clinical trials assessing the optimal management of brain metastases-the state of play. Clin Oncol (R Coll Radiol) 2006;18:744-6. (Pubitemid 44645407)
7. Mulvenna P, Barton R, Wilson P, Faivre-Finn C, Nankivell M, Stephens R, et al. Survival of patients with non-small cell lung cancer and brain metastases. Clin Oncol 2011;23:375-6.
8. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500. (Pubitemid 20067825)
9. Chang EL, Wefel JS, Maor MH, et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 2007;60:277-83.
10. Alexander E, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the defi nitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995;87:34-40.
11. Flickinger JC, Kondziolka D, Lunsford LD, et al. A multiinstitutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994;28:797-802. (Pubitemid 24099860)
12. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363:1665-72. (Pubitemid 38670323)
13. Smalley SR, Laws ER Jr, O ' Fallon JR, Shaw EG, Schray MF. Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients. J Neurosurg 1992;77:531-40.
14. Karlsson B, Hanssens P, Wolff R, Soderman M, Lindquist C, Beute G. Th irty years ' experience with Gamma Knife surgery for metastases to the brain. J Neurosurg 2009;111:449-57.
15. Meisner J, Meyer A, Polivka B, Karstens JH, Bremer M. Outcome of moderately dosed radiosurgery for limited brain metastases: report of a single-center experience. Strahlenther Onkol 2010;186:76-81.
16. Kased N, Binder DK, McDermott MW, et al. Gamma knife radiosurgery for brain metastases from primary breast cancer. Int J Radiation Oncology Biol Phys 2009;75:1132-40.
17. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus w-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295:2483-91. (Pubitemid 43854963)
18. Kocher M, Soffi etti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery of surgial resection of one to three cerebral metastases: results of EORTC 22952-226001 study. J Clin Oncol 2011;29:134-41.
19. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009;10:1037-44.
20. Sun A, Bae K, Gore EM, Movsas B, et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol 2011;29:279-86.
21. Tsao M, Xu, W, Sahgal A. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 2011.